Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

WGS vs NEOG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NEOG Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

NEOG Overall Winner 6-Pillar Tally: WGS 1 – 5 NEOG Matrix Metrics: WGS 1 – 9 NEOG

As of Nov 16, 2026, Neogen Corp (NEOG) is the stronger overall head-to-head candidate over GeneDx Holdings Corp. (WGS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WGS carries a Unified Composite Score of 49.5/100 (HOLD) at $51.02 (40.6x Forward P/E, -13.7% operating margin), whereas NEOG carries 43.0/100 (HOLD) at $10.88 (36.3x Forward P/E, -0.8% operating margin).

  • Composite vs. Pillar Nuance: While WGS currently prints a higher short-term Unified Composite Score (49.5/100 HOLD vs. NEOG 43.0/100 HOLD), NEOG captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (-0.8% vs. -13.7% operating margin) and revenue trajectory (+6.5% vs. +5.4% YoY).
  • Technical & Structure Timing Caution: WGS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8); meanwhile NEOG trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 36.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About WGS vs NEOG
WGS NASDAQ
GeneDx Holdings Corp. Class A Common Stock
Services-Health Services
$51.02
-2.58% 1D
Market Cap $1.6B
TTM Revenue $461M
Forward P/E 40.6x
Beta / 30D Vol 1.74β · 111% Vol
Unified Composite Score
49.5 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 70.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.3%), weak momentum, RSI 35
RSI-14: 34.8 · SMA20: $62.47 · SMA50: $73.13
NEOG NASDAQ Head-to-Head Winner
Neogen Corp
In Vitro & In Vivo Diagnostic Substances
$10.88
-3.12% 1D
Market Cap $2.5B
TTM Revenue $884M
Forward P/E 36.3x
Beta / 30D Vol 1.41β · 40% Vol
Unified Composite Score
43.0 / 100 HOLD
Tech 23.0 Fund 46.0 Flow 61.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 36
RSI-14: 36.3 · SMA20: $11.85 · SMA50: $12.22

6-Pillar Scorecard Institutional Category Breakdown (WGS 1 – 5 NEOG)

Columns: Metric · WGS · NEOG
1. Valuation Multiples NEOG
Forward P/E 40.6x 36.3x
Trailing P/E 38.8x 16.0x
PEG Ratio N/M 0.66x
EV / Revenue 3.7x 3.5x
2. Growth & Scale NEOG
Revenue Growth (YoY) +5.4% +6.5%
Earnings Growth (YoY) +0.0% -85.6%
TTM Revenue (USD) $461M $884M
Market Cap $1.6B $2.5B
3. Profitability & Quality NEOG
Gross Margin 68.8% 47.4%
Operating Margin -13.7% -0.8%
Net Profit Margin -24.1% -6.3%
Return on Equity (ROE) -41.4% -2.7%
4. Balance Sheet & Cash Flow NEOG
Cash Generation (TTM) -$101M $50M
Cash Flow Margin -22.0% 5.6%
Net Cash / Leverage $119M Net Debt (0.88x D/E) $602M Net Debt (0.37x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning NEOG
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 102.3% (21st %ile) 46.0% (25th %ile)
Put/Call OI Skew 7.82x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat WGS
OpEx & R&D Intensity 82.5% of Rev ($380M) 48.2% of Rev ($426M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Diagnostics & Research Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: WGS (1) vs NEOG (9)
Institutional Metric WGS NEOG Criterion Row Edge
Market Capitalization
Scale
$1.6B $2.5B Larger Scale NEOG
Trailing P/E Ratio
Valuation
38.8x 16.0x Lower Multiple NEOG
Forward P/E Ratio
Valuation
40.6x 36.3x Lower Multiple NEOG
Revenue Growth (YoY)
Growth
+5.4% +6.5% Higher Growth NEOG
Operating Margin (TTM)
Profitability
-13.7% -0.8% Higher Margin NEOG
Net Profit Margin
Profitability
-24.1% -6.3% Higher Margin NEOG
Return on Equity (ROE)
Capital Efficiency
-41.4% -2.7% Higher ROE NEOG
52-Week Range Position
Momentum
14% ($32–$171) 62% ($5–$14) Stronger Trend NEOG
Beta / 30D Volatility
Risk Regime
1.74β · 111% Vol 1.41β · 40% Vol Lower Realized Risk NEOG
Unified Institutional Score
Composite Signal
49.5 / 100 (HOLD) 43.0 / 100 (HOLD) Higher Composite WGS
Trailing 12M Revenue (USD)
Operating Scale
$461M $884M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
68.8% 47.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.7x EV/Rev 0.66x PEG · 3.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$101M ($119M Net Debt (0.88x D/E)) $50M ($602M Net Debt (0.37x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NEOG +11.92 pp
WGS: -19.79% · NEOG: -7.87%
3M Horizon NEOG +27.21 pp
WGS: -33.17% · NEOG: -5.96%
6M Horizon NEOG +7.59 pp
WGS: +19.51% · NEOG: +27.1%
1Y Horizon NEOG +131.66 pp
WGS: -60.86% · NEOG: +70.8%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period WGS Revenue NEOG Revenue WGS Op. Margin NEOG Op. Margin Margin Leader
FY2019 $200M $410M -15.5% 16.4% NEOG
FY2020 $180M $420M -134.9% 16.1% NEOG
FY2021 $210M $470M -210.3% 15.8% NEOG
FY2022 $230M $530M -284.5% 11.1% NEOG
FY2023 $200M $820M -89.2% 4.6% NEOG
FY2024 $310M $920M -7.6% 6.3% NEOG
FY2025 $430M $890M -3.1% -118.6% WGS
FY2026 N/A $870M N/A -2.5% NEOG

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
WGS BREAKDOWN
96d in phase · OBV DISTRIBUTION
Current IV 102.3%
IV Percentile 21st %ile
Put/Call OI Skew 7.82x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact WGS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NEOG CONSOLIDATION
39d in phase · OBV NEUTRAL
Current IV 46.0%
IV Percentile 25th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact NEOG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
WGS Moat Profile Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $1.6B market capitalization and -13.7% operating margin.
OpEx & R&D Reinvestment 82.5% of Rev ($380M)
90D Engineering Disclosures 0 Published
NEOG Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $2.5B market capitalization and -0.8% operating margin.
OpEx & R&D Reinvestment 48.2% of Rev ($426M)
90D Engineering Disclosures 0 Published

Investor FAQ WGS vs NEOG Key Questions & Quantitative Answers

As of Nov 16, 2026, Neogen Corp (NEOG) is the stronger overall head-to-head candidate over GeneDx Holdings Corp. (WGS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WGS carries a Unified Composite Score of 49.5/100 (HOLD) at $51.02 (40.6x Forward P/E, -13.7% operating margin), whereas NEOG carries 43.0/100 (HOLD) at $10.88 (36.3x Forward P/E, -0.8% operating margin). Composite vs. Pillar Nuance: While WGS currently prints a higher short-term Unified Composite Score (49.5/100 HOLD vs. NEOG 43.0/100 HOLD), NEOG captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (-0.8% vs. -13.7% operating margin) and revenue trajectory (+6.5% vs. +5.4% YoY). Technical & Structure Timing Caution: WGS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8); meanwhile NEOG trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 36.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NEOG leads the Growth & Scale pillar: WGS posts +5.4% YoY revenue growth and +0.0% YoY earnings growth on $461M TTM revenue (68.8% gross margin, -13.7% operating margin), compared with NEOG at +6.5% YoY revenue growth and -85.6% YoY earnings growth on $884M TTM revenue (47.4% gross margin, -0.8% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), WGS cumulative revenue shifted +115.0% while NEOG shifted +112.2%. In operating R&D and SG&A reinvestment, WGS deploys 82.5% of Rev ($380M) (0 90-day corporate R&D disclosures) versus 48.2% of Rev ($426M) (0 disclosures) for NEOG.

NEOG screens cheaper on headline valuation multiples. WGS trades at 40.6x Forward P/E, 38.8x Trailing P/E, N/M PEG, and 3.7x EV/Revenue (-22.0% FCF margin), whereas NEOG trades at 36.3x Forward P/E, 16.0x Trailing P/E, 0.66x PEG, and 3.5x EV/Revenue (5.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WGS (-41.4% ROE) versus NEOG (-2.7% ROE) capital efficiency.

In options market volatility and institutional positioning, WGS carries 102.3% implied volatility (21st %ile, Compressed (<25th %ile)), a 7.82x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.74β · 111% Vol realized risk). By comparison, NEOG carries 46.0% implied volatility (25th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.41β · 40% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.